Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in total parenteral nutrition in patients with hematologic malignancies undergoing peripheral blood stem cell transplantation
S. Demirer et al., Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in total parenteral nutrition in patients with hematologic malignancies undergoing peripheral blood stem cell transplantation, CLIN NUTR, 19(4), 2000, pp. 253-258
Background and aims:The purpose of this randomized study was to compare the
efficacy of medium chain triglycerides (MCT) plus long chain triglycerides
(LCT) with LCT alone in total parenteral nutrition (TPN) solutions in pati
ents with various hematologic malignancies who underwent a hematopoietic pe
ripheral blood stem cell (PBSC) transplantation.
Methods: Of 36 patients entering into this study, 18 received MCT + LCT (gr
oup I) and the remaining 18 received LCT alone (group II) in TPN solutions.
Patients were comparable regarding age, gender, donor-recipient gender, di
agnosis, body weights, blood group differences and number of infused CD34cells/kg. Post-transplant parameters such as duration of platelet and neutr
ophil engraftment, coagulation parameters, number of days of febrile neutro
penia and antibiotic administration, plasma glucose, triglyceride, choleste
rol and albumin levels, graft-versus-host disease (GVHD) and first 100 day
mortality were compared in both groups.
Results: Median days of neutrophil >0.5 x 10(9)/l and platelet of >20 x 10(
9)/l in group I and group II were 15 (range, 8-21), 11 (10-29) and 14 (rang
e, 9-31), 13 (9-18) respectively (P > 0.05). Median days of febrile neutrop
enia in group I and II were 10 (range, 4-23) and 7 (2-13) respectively (P=0
.01). Median days of antibiotic administration in group I and II were 12 (r
ange, 6-22) and 8 (4-25) respectively (P=0.04). Pre, peri- and post-transpl
ant coagulation parameters such as PT, aPTT, and fibrinogen did not differ
significantly between two groups (P > 0.05), as well as plasma glucose, tri
glyceride, cholesterol, albumin levels, GVHD and first 100 day mortality.
Conclusion: There was no difference between patients receiving MCT + LCT (g
roup I) and LCT alone (group II) in TPN solutions regarding duration of eng
raftment and coagulation parameters, but numbers of median days of febrile
neutropenia and days of antibiotic administration were significantly shorte
r in patients receiving LCT alone (group II) than those receiving MCT + LCT
(P < 0.01 and 0.04 respectively). (C) 2000 Harcourt Publishers Ltd.